000 01109 a2200325 4500
005 20250516112247.0
264 0 _c20130620
008 201306s 0 0 eng d
022 _a1879-016X
024 7 _a10.1016/j.pharmthera.2012.09.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Thuijl, H F
245 0 0 _aGenetics and pharmacogenomics of diffuse gliomas.
_h[electronic resource]
260 _bPharmacology & therapeutics
_cJan 2013
300 _a78-88 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aBrain Neoplasms
_xgenetics
650 0 4 _aGlioma
_xgenetics
650 0 4 _aHumans
650 0 4 _aPharmacogenetics
700 1 _aYlstra, B
700 1 _aWürdinger, T
700 1 _avan Nieuwenhuizen, D
700 1 _aHeimans, J J
700 1 _aWesseling, P
700 1 _aReijneveld, J C
773 0 _tPharmacology & therapeutics
_gvol. 137
_gno. 1
_gp. 78-88
856 4 0 _uhttps://doi.org/10.1016/j.pharmthera.2012.09.002
_zAvailable from publisher's website
999 _c22111343
_d22111343